2409TiP A global, multicentre, open-label, randomised phase II trial of tobemstomig (tobe) with or without tiragolumab (tira) vs atezolizumab (atezo) in patients (pts) with untreated metastatic urothelial cancer (mUC) ineligible for platinum-based chemotherapy (chemo)

S. Gupta, O. Alhalabi, A. Bamias, J. Bellmunt,D.E. Castellano Gauna, J. Bedke, T. Friedlander, B. Garmezy, P. Grivas, R.A. Huddart, A. Necchi, T.B. Powles,J. Puente, D.A.R. Da Rosa, F. Wang, C. Lambertini, A. Andreev-Drakhlin, M. Fasso, Y. Loriot

Annals of Oncology（2023）

引用 1|浏览0

暂无评分

关键词

untreated metastatic urothelial cancer,chemotherapy,atezolizumab,tobemstomig,tobemstomig,open-label,platinum-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要